Sean Grant - 06 Feb 2023 Form 4/A - Amendment Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Chief Financial Officer
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
06 Feb 2023
Net transactions value
+$99,995
Form type
4/A - Amendment
Filing time
17 Feb 2023, 15:17:30 UTC
Date Of Original Report
08 Feb 2023
Previous filing
23 Aug 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Purchase $99,995 +14,285 +40% $7.00 49,933 06 Feb 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person's original Form 4 contained a typographical error on the transaction date.
F2 Shares purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 6, 2023. The purchase price is the offering price.
F3 Includes 380 shares acquired under the Issuer's Employee Stock Purchase Plan on September 13, 2022.